PATENT CLAIM ANALYSIS

Application Number: 16142263
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "275000"]

Abstract:
The present disclosure relates to a new pharmaceutical composition comprising Ceritinib. Particularly it is directed to the tablet that is prepared by wet granulation, wherein povidone is used as a binder. Further feature of the composition is that the drug and the binder form the inner phase, whereas all other excipients are added in a powder form as an outer phase. This way, the sticking of the composition is prevented and sufficient tablet hardness can be reached.

Claim (Index 13):
The pharmaceutical composition according to  claim 1  or the tablet according to  claim 10 , for use as a medicine.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 97.0
- Lexical Diversity: 1.5
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15852125', '13255326', '13824776', '15159008', '13810346']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7269287503891048
- 35 USC 102 Novelty (BERT): 0.516153373021743
- Combined Prediction Score: 0.7058512126523686
- Mean Citation Score: 256.696736
- Max Citation Score: 266.40668
- Similarity Product: 185.26916135072943

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test